A study of the clinical significance of mSEPT9 in monitoring recurrence and prognosis in patients with surgically treated colorectal cancer

To explore the medical significance of methylated septin9 (mSEPT9) in monitoring recurrence and prognostic assessment in individuals with surgically treated colorectal cancer (CRC). To investigate the role of Septin9 in colorectal cancer, we utilized the TIMER2.0 database to analyze its differential...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 19; no. 10; p. e0312676
Main Authors Li, Rong, Chen, Jiaojiao, Shen, Xin, Lin, Yanping, Tang, Jiadai, Xiong, Guangrui, Zhang, Ke, Xiang, Mengying, Xie, Lin, Hu, Fengdi
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 28.10.2024
Public Library of Science (PLoS)
Subjects
Aged
Bioinformatics
Biology and life sciences
Biomarkers, Tumor - blood
Biomarkers, Tumor - genetics
Blood
Blood levels
Cancer
Cancer therapies
Carcinoembryonic antigen
Carcinoembryonic Antigen - blood
Carcinogenesis
Carcinogens
Care and treatment
Clinical medicine
Clinical Relevance
Clinical significance
Colon cancer
Colorectal cancer
Colorectal carcinoma
Colorectal Neoplasms - diagnosis
Colorectal Neoplasms - genetics
Colorectal Neoplasms - pathology
Colorectal Neoplasms - surgery
Differentiation
DNA Methylation
Female
Gene expression
Gene Expression Regulation, Neoplastic
Humans
Male
Medical prognosis
Medicine and Health Sciences
Metastasis
Middle Aged
Monitoring
Mortality
mRNA
Neoplasm Recurrence, Local - genetics
Patients
Peripheral blood
Physical Sciences
Plasma
Predictions
Prognosis
Relapse
Risk factors
Septins - genetics
Septins - metabolism
Spliceosomes
Statistical analysis
Surgery
Survival
Survival analysis
Telemedicine
Tissues
Tumors
China
Online AccessGet full text

Cover

Abstract To explore the medical significance of methylated septin9 (mSEPT9) in monitoring recurrence and prognostic assessment in individuals with surgically treated colorectal cancer (CRC). To investigate the role of Septin9 in colorectal cancer, we utilized the TIMER2.0 database to analyze its differential expression between tumor tissues and adjacent normal tissues. Colorectal cancer RNA-seq data from the TCGA database was downloaded and curated. The clinical relevance of mSEPT9 in colorectal cancer was explored by examining the correlation between Septin9 methylation levels and clinical characteristics using UALCAN and MethSurv software. Peripheral blood samples were obtained from 130 CRC subjects who underwent surgery for the detection of mSEPT9 and carcinoembryonic antigen (CEA) expression, along with collection of clinicopathological data such as age, gender, tumor site, TNM stage, and tumor differentiation. Patients were followed up for at least 3 years post-surgery until the death or final follow-up dates (31/12/2022). Additionally, peripheral blood samples were collected from 30 colorectal cancer surgery patients for mSEPT9 detection before and 7 days after surgery. Through bioinformatic database analysis, we identified higher expression levels of SEPT9 mRNA in most tumor tissues compared to normal tissues. Similarly, both paired and unpaired CRC tissues exhibited elevated expression of Septin9 when compared to normal tissues. Following GO and KEGG analysis of Septin9 target genes, we discovered their significant associations with ncRNA metabolic processes, ribonucleoprotein complex biogenesis, spliceosomes, and viral carcinogenesis. Furthermore, the overexpression of mSeptin9 was observed in CRC tissues, and it demonstrated a correlation with colon cancer staging and histologic classification. In our clinical sample study, The positive rate of mSEPT9 in CRC patients 7 days after surgery was 43.44% lower than that of preoperative. The differences in TNM stage, tumor differentiation degree, and preoperative CEA expression level between the preoperative mSEPT9 positive and negative groups of CRC were statistically significant (P < 0.05). Recurrence free survival (RFS) and overall survival (OS) were shorter in the preoperative mSEPT9-positive group, meaning preoperative mSEPT9 status was a risk factor for CRC recurrence and prognosis (P < 0.05). The sensitivity, specificity, and AUC value of preoperative mSEPT9 and CEA levels for predicting postoperative recurrence in CRC patients were 88% vs. 72%, 56.19% vs. 55.24%, and 0.721 vs. 0.636 respectively, well the AUC value of the combined prediction of postoperative recurrence was 0.758. The detection of mSEPT9 combined with CEA in preoperative plasma helps predict recurrence in colorectal cancer patients.
AbstractList ObjectiveTo explore the medical significance of methylated septin9 (mSEPT9) in monitoring recurrence and prognostic assessment in individuals with surgically treated colorectal cancer (CRC).MethodsTo investigate the role of Septin9 in colorectal cancer, we utilized the TIMER2.0 database to analyze its differential expression between tumor tissues and adjacent normal tissues. Colorectal cancer RNA-seq data from the TCGA database was downloaded and curated. The clinical relevance of mSEPT9 in colorectal cancer was explored by examining the correlation between Septin9 methylation levels and clinical characteristics using UALCAN and MethSurv software. Peripheral blood samples were obtained from 130 CRC subjects who underwent surgery for the detection of mSEPT9 and carcinoembryonic antigen (CEA) expression, along with collection of clinicopathological data such as age, gender, tumor site, TNM stage, and tumor differentiation. Patients were followed up for at least 3 years post-surgery until the death or final follow-up dates (31/12/2022). Additionally, peripheral blood samples were collected from 30 colorectal cancer surgery patients for mSEPT9 detection before and 7 days after surgery.ResultsThrough bioinformatic database analysis, we identified higher expression levels of SEPT9 mRNA in most tumor tissues compared to normal tissues. Similarly, both paired and unpaired CRC tissues exhibited elevated expression of Septin9 when compared to normal tissues. Following GO and KEGG analysis of Septin9 target genes, we discovered their significant associations with ncRNA metabolic processes, ribonucleoprotein complex biogenesis, spliceosomes, and viral carcinogenesis. Furthermore, the overexpression of mSeptin9 was observed in CRC tissues, and it demonstrated a correlation with colon cancer staging and histologic classification. In our clinical sample study, The positive rate of mSEPT9 in CRC patients 7 days after surgery was 43.44% lower than that of preoperative. The differences in TNM stage, tumor differentiation degree, and preoperative CEA expression level between the preoperative mSEPT9 positive and negative groups of CRC were statistically significant (P < 0.05). Recurrence free survival (RFS) and overall survival (OS) were shorter in the preoperative mSEPT9-positive group, meaning preoperative mSEPT9 status was a risk factor for CRC recurrence and prognosis (P < 0.05). The sensitivity, specificity, and AUC value of preoperative mSEPT9 and CEA levels for predicting postoperative recurrence in CRC patients were 88% vs. 72%, 56.19% vs. 55.24%, and 0.721 vs. 0.636 respectively, well the AUC value of the combined prediction of postoperative recurrence was 0.758.ConclusionThe detection of mSEPT9 combined with CEA in preoperative plasma helps predict recurrence in colorectal cancer patients.
To explore the medical significance of methylated septin9 (mSEPT9) in monitoring recurrence and prognostic assessment in individuals with surgically treated colorectal cancer (CRC). To investigate the role of Septin9 in colorectal cancer, we utilized the TIMER2.0 database to analyze its differential expression between tumor tissues and adjacent normal tissues. Colorectal cancer RNA-seq data from the TCGA database was downloaded and curated. The clinical relevance of mSEPT9 in colorectal cancer was explored by examining the correlation between Septin9 methylation levels and clinical characteristics using UALCAN and MethSurv software. Peripheral blood samples were obtained from 130 CRC subjects who underwent surgery for the detection of mSEPT9 and carcinoembryonic antigen (CEA) expression, along with collection of clinicopathological data such as age, gender, tumor site, TNM stage, and tumor differentiation. Patients were followed up for at least 3 years post-surgery until the death or final follow-up dates (31/12/2022). Additionally, peripheral blood samples were collected from 30 colorectal cancer surgery patients for mSEPT9 detection before and 7 days after surgery. Through bioinformatic database analysis, we identified higher expression levels of SEPT9 mRNA in most tumor tissues compared to normal tissues. Similarly, both paired and unpaired CRC tissues exhibited elevated expression of Septin9 when compared to normal tissues. Following GO and KEGG analysis of Septin9 target genes, we discovered their significant associations with ncRNA metabolic processes, ribonucleoprotein complex biogenesis, spliceosomes, and viral carcinogenesis. Furthermore, the overexpression of mSeptin9 was observed in CRC tissues, and it demonstrated a correlation with colon cancer staging and histologic classification. In our clinical sample study, The positive rate of mSEPT9 in CRC patients 7 days after surgery was 43.44% lower than that of preoperative. The differences in TNM stage, tumor differentiation degree, and preoperative CEA expression level between the preoperative mSEPT9 positive and negative groups of CRC were statistically significant (P < 0.05). Recurrence free survival (RFS) and overall survival (OS) were shorter in the preoperative mSEPT9-positive group, meaning preoperative mSEPT9 status was a risk factor for CRC recurrence and prognosis (P < 0.05). The sensitivity, specificity, and AUC value of preoperative mSEPT9 and CEA levels for predicting postoperative recurrence in CRC patients were 88% vs. 72%, 56.19% vs. 55.24%, and 0.721 vs. 0.636 respectively, well the AUC value of the combined prediction of postoperative recurrence was 0.758. The detection of mSEPT9 combined with CEA in preoperative plasma helps predict recurrence in colorectal cancer patients.
Objective To explore the medical significance of methylated septin9 (mSEPT9) in monitoring recurrence and prognostic assessment in individuals with surgically treated colorectal cancer (CRC). Methods To investigate the role of Septin9 in colorectal cancer, we utilized the TIMER2.0 database to analyze its differential expression between tumor tissues and adjacent normal tissues. Colorectal cancer RNA-seq data from the TCGA database was downloaded and curated. The clinical relevance of mSEPT9 in colorectal cancer was explored by examining the correlation between Septin9 methylation levels and clinical characteristics using UALCAN and MethSurv software. Peripheral blood samples were obtained from 130 CRC subjects who underwent surgery for the detection of mSEPT9 and carcinoembryonic antigen (CEA) expression, along with collection of clinicopathological data such as age, gender, tumor site, TNM stage, and tumor differentiation. Patients were followed up for at least 3 years post-surgery until the death or final follow-up dates (31/12/2022). Additionally, peripheral blood samples were collected from 30 colorectal cancer surgery patients for mSEPT9 detection before and 7 days after surgery. Results Through bioinformatic database analysis, we identified higher expression levels of SEPT9 mRNA in most tumor tissues compared to normal tissues. Similarly, both paired and unpaired CRC tissues exhibited elevated expression of Septin9 when compared to normal tissues. Following GO and KEGG analysis of Septin9 target genes, we discovered their significant associations with ncRNA metabolic processes, ribonucleoprotein complex biogenesis, spliceosomes, and viral carcinogenesis. Furthermore, the overexpression of mSeptin9 was observed in CRC tissues, and it demonstrated a correlation with colon cancer staging and histologic classification. In our clinical sample study, The positive rate of mSEPT9 in CRC patients 7 days after surgery was 43.44% lower than that of preoperative. The differences in TNM stage, tumor differentiation degree, and preoperative CEA expression level between the preoperative mSEPT9 positive and negative groups of CRC were statistically significant ( P < 0.05). Recurrence free survival (RFS) and overall survival (OS) were shorter in the preoperative mSEPT9-positive group, meaning preoperative mSEPT9 status was a risk factor for CRC recurrence and prognosis ( P < 0.05). The sensitivity, specificity, and AUC value of preoperative mSEPT9 and CEA levels for predicting postoperative recurrence in CRC patients were 88% vs. 72%, 56.19% vs. 55.24%, and 0.721 vs. 0.636 respectively, well the AUC value of the combined prediction of postoperative recurrence was 0.758. Conclusion The detection of mSEPT9 combined with CEA in preoperative plasma helps predict recurrence in colorectal cancer patients.
Objective To explore the medical significance of methylated septin9 (mSEPT9) in monitoring recurrence and prognostic assessment in individuals with surgically treated colorectal cancer (CRC). Methods To investigate the role of Septin9 in colorectal cancer, we utilized the TIMER2.0 database to analyze its differential expression between tumor tissues and adjacent normal tissues. Colorectal cancer RNA-seq data from the TCGA database was downloaded and curated. The clinical relevance of mSEPT9 in colorectal cancer was explored by examining the correlation between Septin9 methylation levels and clinical characteristics using UALCAN and MethSurv software. Peripheral blood samples were obtained from 130 CRC subjects who underwent surgery for the detection of mSEPT9 and carcinoembryonic antigen (CEA) expression, along with collection of clinicopathological data such as age, gender, tumor site, TNM stage, and tumor differentiation. Patients were followed up for at least 3 years post-surgery until the death or final follow-up dates (31/12/2022). Additionally, peripheral blood samples were collected from 30 colorectal cancer surgery patients for mSEPT9 detection before and 7 days after surgery. Results Through bioinformatic database analysis, we identified higher expression levels of SEPT9 mRNA in most tumor tissues compared to normal tissues. Similarly, both paired and unpaired CRC tissues exhibited elevated expression of Septin9 when compared to normal tissues. Following GO and KEGG analysis of Septin9 target genes, we discovered their significant associations with ncRNA metabolic processes, ribonucleoprotein complex biogenesis, spliceosomes, and viral carcinogenesis. Furthermore, the overexpression of mSeptin9 was observed in CRC tissues, and it demonstrated a correlation with colon cancer staging and histologic classification. In our clinical sample study, The positive rate of mSEPT9 in CRC patients 7 days after surgery was 43.44% lower than that of preoperative. The differences in TNM stage, tumor differentiation degree, and preoperative CEA expression level between the preoperative mSEPT9 positive and negative groups of CRC were statistically significant (P < 0.05). Recurrence free survival (RFS) and overall survival (OS) were shorter in the preoperative mSEPT9-positive group, meaning preoperative mSEPT9 status was a risk factor for CRC recurrence and prognosis (P < 0.05). The sensitivity, specificity, and AUC value of preoperative mSEPT9 and CEA levels for predicting postoperative recurrence in CRC patients were 88% vs. 72%, 56.19% vs. 55.24%, and 0.721 vs. 0.636 respectively, well the AUC value of the combined prediction of postoperative recurrence was 0.758. Conclusion The detection of mSEPT9 combined with CEA in preoperative plasma helps predict recurrence in colorectal cancer patients.
To explore the medical significance of methylated septin9 (mSEPT9) in monitoring recurrence and prognostic assessment in individuals with surgically treated colorectal cancer (CRC).OBJECTIVETo explore the medical significance of methylated septin9 (mSEPT9) in monitoring recurrence and prognostic assessment in individuals with surgically treated colorectal cancer (CRC).To investigate the role of Septin9 in colorectal cancer, we utilized the TIMER2.0 database to analyze its differential expression between tumor tissues and adjacent normal tissues. Colorectal cancer RNA-seq data from the TCGA database was downloaded and curated. The clinical relevance of mSEPT9 in colorectal cancer was explored by examining the correlation between Septin9 methylation levels and clinical characteristics using UALCAN and MethSurv software. Peripheral blood samples were obtained from 130 CRC subjects who underwent surgery for the detection of mSEPT9 and carcinoembryonic antigen (CEA) expression, along with collection of clinicopathological data such as age, gender, tumor site, TNM stage, and tumor differentiation. Patients were followed up for at least 3 years post-surgery until the death or final follow-up dates (31/12/2022). Additionally, peripheral blood samples were collected from 30 colorectal cancer surgery patients for mSEPT9 detection before and 7 days after surgery.METHODSTo investigate the role of Septin9 in colorectal cancer, we utilized the TIMER2.0 database to analyze its differential expression between tumor tissues and adjacent normal tissues. Colorectal cancer RNA-seq data from the TCGA database was downloaded and curated. The clinical relevance of mSEPT9 in colorectal cancer was explored by examining the correlation between Septin9 methylation levels and clinical characteristics using UALCAN and MethSurv software. Peripheral blood samples were obtained from 130 CRC subjects who underwent surgery for the detection of mSEPT9 and carcinoembryonic antigen (CEA) expression, along with collection of clinicopathological data such as age, gender, tumor site, TNM stage, and tumor differentiation. Patients were followed up for at least 3 years post-surgery until the death or final follow-up dates (31/12/2022). Additionally, peripheral blood samples were collected from 30 colorectal cancer surgery patients for mSEPT9 detection before and 7 days after surgery.Through bioinformatic database analysis, we identified higher expression levels of SEPT9 mRNA in most tumor tissues compared to normal tissues. Similarly, both paired and unpaired CRC tissues exhibited elevated expression of Septin9 when compared to normal tissues. Following GO and KEGG analysis of Septin9 target genes, we discovered their significant associations with ncRNA metabolic processes, ribonucleoprotein complex biogenesis, spliceosomes, and viral carcinogenesis. Furthermore, the overexpression of mSeptin9 was observed in CRC tissues, and it demonstrated a correlation with colon cancer staging and histologic classification. In our clinical sample study, The positive rate of mSEPT9 in CRC patients 7 days after surgery was 43.44% lower than that of preoperative. The differences in TNM stage, tumor differentiation degree, and preoperative CEA expression level between the preoperative mSEPT9 positive and negative groups of CRC were statistically significant (P < 0.05). Recurrence free survival (RFS) and overall survival (OS) were shorter in the preoperative mSEPT9-positive group, meaning preoperative mSEPT9 status was a risk factor for CRC recurrence and prognosis (P < 0.05). The sensitivity, specificity, and AUC value of preoperative mSEPT9 and CEA levels for predicting postoperative recurrence in CRC patients were 88% vs. 72%, 56.19% vs. 55.24%, and 0.721 vs. 0.636 respectively, well the AUC value of the combined prediction of postoperative recurrence was 0.758.RESULTSThrough bioinformatic database analysis, we identified higher expression levels of SEPT9 mRNA in most tumor tissues compared to normal tissues. Similarly, both paired and unpaired CRC tissues exhibited elevated expression of Septin9 when compared to normal tissues. Following GO and KEGG analysis of Septin9 target genes, we discovered their significant associations with ncRNA metabolic processes, ribonucleoprotein complex biogenesis, spliceosomes, and viral carcinogenesis. Furthermore, the overexpression of mSeptin9 was observed in CRC tissues, and it demonstrated a correlation with colon cancer staging and histologic classification. In our clinical sample study, The positive rate of mSEPT9 in CRC patients 7 days after surgery was 43.44% lower than that of preoperative. The differences in TNM stage, tumor differentiation degree, and preoperative CEA expression level between the preoperative mSEPT9 positive and negative groups of CRC were statistically significant (P < 0.05). Recurrence free survival (RFS) and overall survival (OS) were shorter in the preoperative mSEPT9-positive group, meaning preoperative mSEPT9 status was a risk factor for CRC recurrence and prognosis (P < 0.05). The sensitivity, specificity, and AUC value of preoperative mSEPT9 and CEA levels for predicting postoperative recurrence in CRC patients were 88% vs. 72%, 56.19% vs. 55.24%, and 0.721 vs. 0.636 respectively, well the AUC value of the combined prediction of postoperative recurrence was 0.758.The detection of mSEPT9 combined with CEA in preoperative plasma helps predict recurrence in colorectal cancer patients.CONCLUSIONThe detection of mSEPT9 combined with CEA in preoperative plasma helps predict recurrence in colorectal cancer patients.
To explore the medical significance of methylated septin9 (mSEPT9) in monitoring recurrence and prognostic assessment in individuals with surgically treated colorectal cancer (CRC). To investigate the role of Septin9 in colorectal cancer, we utilized the TIMER2.0 database to analyze its differential expression between tumor tissues and adjacent normal tissues. Colorectal cancer RNA-seq data from the TCGA database was downloaded and curated. The clinical relevance of mSEPT9 in colorectal cancer was explored by examining the correlation between Septin9 methylation levels and clinical characteristics using UALCAN and MethSurv software. Peripheral blood samples were obtained from 130 CRC subjects who underwent surgery for the detection of mSEPT9 and carcinoembryonic antigen (CEA) expression, along with collection of clinicopathological data such as age, gender, tumor site, TNM stage, and tumor differentiation. Patients were followed up for at least 3 years post-surgery until the death or final follow-up dates (31/12/2022). Additionally, peripheral blood samples were collected from 30 colorectal cancer surgery patients for mSEPT9 detection before and 7 days after surgery. Through bioinformatic database analysis, we identified higher expression levels of SEPT9 mRNA in most tumor tissues compared to normal tissues. Similarly, both paired and unpaired CRC tissues exhibited elevated expression of Septin9 when compared to normal tissues. Following GO and KEGG analysis of Septin9 target genes, we discovered their significant associations with ncRNA metabolic processes, ribonucleoprotein complex biogenesis, spliceosomes, and viral carcinogenesis. Furthermore, the overexpression of mSeptin9 was observed in CRC tissues, and it demonstrated a correlation with colon cancer staging and histologic classification. In our clinical sample study, The positive rate of mSEPT9 in CRC patients 7 days after surgery was 43.44% lower than that of preoperative. The differences in TNM stage, tumor differentiation degree, and preoperative CEA expression level between the preoperative mSEPT9 positive and negative groups of CRC were statistically significant (P < 0.05). Recurrence free survival (RFS) and overall survival (OS) were shorter in the preoperative mSEPT9-positive group, meaning preoperative mSEPT9 status was a risk factor for CRC recurrence and prognosis (P < 0.05). The sensitivity, specificity, and AUC value of preoperative mSEPT9 and CEA levels for predicting postoperative recurrence in CRC patients were 88% vs. 72%, 56.19% vs. 55.24%, and 0.721 vs. 0.636 respectively, well the AUC value of the combined prediction of postoperative recurrence was 0.758. The detection of mSEPT9 combined with CEA in preoperative plasma helps predict recurrence in colorectal cancer patients.
Audience Academic
Author Zhang, Ke
Li, Rong
Hu, Fengdi
Xie, Lin
Chen, Jiaojiao
Tang, Jiadai
Lin, Yanping
Shen, Xin
Xiong, Guangrui
Xiang, Mengying
AuthorAffiliation 2 Radiotherapy Department, The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan Province, China
3 Gastroenterology, Lincang People’s Hospital, Lincang, Yunnan Province, China
4 Department of Oncology, Baoshan People’s Hospital in Yunnan Province, Baoshan, Yunnan Province, China
University Magna Graecia of Catanzaro, ITALY
1 Department of Digestive Neoplasms, Peking University Cancer Hospital Yunnan, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming, Yunnan Province, China
5 Department of Critical Care Medicine, Peking University Cancer Hospital Yunnan, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming, Yunnan Province, China
AuthorAffiliation_xml – name: University Magna Graecia of Catanzaro, ITALY
– name: 2 Radiotherapy Department, The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan Province, China
– name: 5 Department of Critical Care Medicine, Peking University Cancer Hospital Yunnan, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming, Yunnan Province, China
– name: 1 Department of Digestive Neoplasms, Peking University Cancer Hospital Yunnan, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming, Yunnan Province, China
– name: 3 Gastroenterology, Lincang People’s Hospital, Lincang, Yunnan Province, China
– name: 4 Department of Oncology, Baoshan People’s Hospital in Yunnan Province, Baoshan, Yunnan Province, China
Author_xml – sequence: 1
  givenname: Rong
  orcidid: 0000-0002-9696-4925
  surname: Li
  fullname: Li, Rong
– sequence: 2
  givenname: Jiaojiao
  surname: Chen
  fullname: Chen, Jiaojiao
– sequence: 3
  givenname: Xin
  surname: Shen
  fullname: Shen, Xin
– sequence: 4
  givenname: Yanping
  surname: Lin
  fullname: Lin, Yanping
– sequence: 5
  givenname: Jiadai
  surname: Tang
  fullname: Tang, Jiadai
– sequence: 6
  givenname: Guangrui
  surname: Xiong
  fullname: Xiong, Guangrui
– sequence: 7
  givenname: Ke
  surname: Zhang
  fullname: Zhang, Ke
– sequence: 8
  givenname: Mengying
  surname: Xiang
  fullname: Xiang, Mengying
– sequence: 9
  givenname: Lin
  surname: Xie
  fullname: Xie, Lin
– sequence: 10
  givenname: Fengdi
  surname: Hu
  fullname: Hu, Fengdi
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39466813$$D View this record in MEDLINE/PubMed
BookMark eNqNk99u0zAUxiM0xP7AGyCwhITgosWOE6e-QtU0oNKkITa4tRznJHXl2p3tAH0GXhpnzaYW7QLlItbxz99nfzrnNDuyzkKWvSR4SmhFPqxc7600000qTzElOavYk-yEcJpPWI7p0d76ODsNYYVxSWeMPcuOKS8YmxF6kv2ZoxD7Zotci-ISkDLaaiUNCrqzuk1Lq2DYXF9ffL3hSFu0dlZH57XtkAfVew8DIm2DNt511gUdBmwjowYbA_ql4xKF3neDrtmi6EFGaJByxiWBmMzuXPzz7GkrTYAX4_8s-_7p4ub8y-Ty6vPifH45UazI4wQ4Ji3OeV6qSqm2pTUUDZeNqjjwFhRpaqAtZjkt6kpBIVlZNjXNlZQ0rySmZ9nrne7GuCDGHINIEZKypJwViVjsiMbJldh4vZZ-K5zU4q7gfCekj1oZEDXlhM_qsqhYmawaPmNJRmFFMeeM50nr4-jW12toVMrES3Mgerhj9VJ07qcgpCQlnw23eTcqeHfbQ4hirYMCY6QF148X5zgvaELf_IM-_ryR6mR6gbatS8ZqEBXz1BWclbwgiZo-QqWvgbVWqetaneoHB94fHEhMhN-xk30IYnH97f_Zqx-H7Ns9dgnSxGVwpo_a2XAIvtqP-iHj-3ZPQLEDlHcheGgfEILFMFX3cYlhqsQ4VfQvxNkVYA
Cites_doi 10.1007/s12253-018-0559-5
10.14309/ctg.0000000000000386
10.1096/fj.201902750RR
10.1186/s12967-023-03884-3
10.1042/EBC20190037
10.1373/clinchem.2007.095992
10.1016/j.jncc.2022.02.002
10.1111/apt.16824
10.1038/s41419-018-0547-4
10.1056/NEJMoa2200075
10.2217/bmm-2018-0012
10.3389/fmolb.2021.568818
10.1186/1471-2407-13-398
10.1016/j.jss.2021.06.008
10.1001/jama.2021.0106
10.1515/BC.2011.088
10.1186/s12885-019-5663-8
10.1038/s43018-020-0096-5
10.3390/cancers14143510
10.1016/j.cca.2022.10.019
10.1016/j.taap.2016.12.002
10.3322/caac.21660
10.2217/epi-2021-0080
10.1200/JCO.21.02615
ContentType Journal Article
Copyright Copyright: © 2024 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
COPYRIGHT 2024 Public Library of Science
2024 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2024 Li et al 2024 Li et al
2024 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: Copyright: © 2024 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
– notice: COPYRIGHT 2024 Public Library of Science
– notice: 2024 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2024 Li et al 2024 Li et al
– notice: 2024 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0312676
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
ProQuest SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agricultural Science Database
Health & Medical Collection (Alumni)
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Agricultural Science Database





MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
DocumentTitleAlternate mSEPT9 in monitoring recurrence and prognosis in CRC
EISSN 1932-6203
ExternalDocumentID 3121553964
oai_doaj_org_article_b39198b547654a6d986215c0c3099692
PMC11515984
A813965941
39466813
10_1371_journal_pone_0312676
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: ;
  grantid: 202101AY070001-177
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
ADRAZ
BBORY
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
RIG
PMFND
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c642t-e901f02925c7ccff3be4d9adc79e9fec1dbe3f06234b7ce4a655db32caa327a03
IEDL.DBID 7X7
ISSN 1932-6203
IngestDate Wed Aug 13 01:18:43 EDT 2025
Wed Aug 27 01:19:22 EDT 2025
Thu Aug 21 18:44:07 EDT 2025
Tue Aug 05 11:10:52 EDT 2025
Fri Jul 25 11:32:49 EDT 2025
Tue Jun 17 22:02:27 EDT 2025
Tue Jun 10 21:03:47 EDT 2025
Fri Jun 27 05:27:33 EDT 2025
Fri Jun 27 05:27:34 EDT 2025
Thu May 22 21:24:14 EDT 2025
Thu Apr 03 07:07:45 EDT 2025
Tue Jul 01 01:56:30 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License Copyright: © 2024 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c642t-e901f02925c7ccff3be4d9adc79e9fec1dbe3f06234b7ce4a655db32caa327a03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors contributed equally to this work and share first authorship on this work
Competing Interests: The authors have declared that no competing interests exist.
ORCID 0000-0002-9696-4925
OpenAccessLink https://www.proquest.com/docview/3121553964?pq-origsite=%requestingapplication%
PMID 39466813
PQID 3121553964
PQPubID 1436336
PageCount e0312676
ParticipantIDs plos_journals_3121553964
doaj_primary_oai_doaj_org_article_b39198b547654a6d986215c0c3099692
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11515984
proquest_miscellaneous_3121590243
proquest_journals_3121553964
gale_infotracmisc_A813965941
gale_infotracacademiconefile_A813965941
gale_incontextgauss_ISR_A813965941
gale_incontextgauss_IOV_A813965941
gale_healthsolutions_A813965941
pubmed_primary_39466813
crossref_primary_10_1371_journal_pone_0312676
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-10-28
PublicationDateYYYYMMDD 2024-10-28
PublicationDate_xml – month: 10
  year: 2024
  text: 2024-10-28
  day: 28
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2024
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References Z Gao (pone.0312676.ref006) 2023; 21
D Xu (pone.0312676.ref024) 2018; 9
A Füchtbauer (pone.0312676.ref021) 2011; 392
Y Wu (pone.0312676.ref025) 2017; 315
C Lofton-Day (pone.0312676.ref008) 2008; 54
J Tie (pone.0312676.ref005) 2022; 386
M Malla (pone.0312676.ref009) 2022; 40
G Sun (pone.0312676.ref011) 2019; 25
ELSA van Liere (pone.0312676.ref012) 2022; 55
W Liu (pone.0312676.ref016) 2021; 267
RS Zheng (pone.0312676.ref004) 2019; 41
K Skvortsova (pone.0312676.ref007) 2019; 63
R Zheng (pone.0312676.ref002) 2022; 2
ME van de Velde (pone.0312676.ref020) 2022; 14
F Xu (pone.0312676.ref014) 2021; 12
R Wasserkort (pone.0312676.ref022) 2013; 13
J Xu (pone.0312676.ref013) 2021; 13
JJ Gao (pone.0312676.ref017) 2022; 537
L Song (pone.0312676.ref015) 2018; 12
N Kang (pone.0312676.ref023) 2020; 34
J Sun (pone.0312676.ref018) 2019; 19
LH Biller (pone.0312676.ref003) 2021; 325
H Sung (pone.0312676.ref001) 2021; 71
J Sun (pone.0312676.ref019) 2021; 8
SV Bratman (pone.0312676.ref010) 2020; 1
References_xml – volume: 25
  start-page: 1525
  issue: 4
  year: 2019
  ident: pone.0312676.ref011
  article-title: Diagnostic Assessment of septin9 DNA Methylation for Colorectal Cancer Using Blood Detection: A Meta-Analysis.
  publication-title: Pathol Oncol Res
  doi: 10.1007/s12253-018-0559-5
– volume: 12
  start-page: e00386
  issue: 8
  year: 2021
  ident: pone.0312676.ref014
  article-title: Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer.
  publication-title: Clin Transl Gastroenterol
  doi: 10.14309/ctg.0000000000000386
– volume: 41
  start-page: 19
  issue: 1
  year: 2019
  ident: pone.0312676.ref004
  article-title: [Report of cancer epidemiology in China, 2015].
  publication-title: Zhonghua Zhong Liu Za Zhi.
– volume: 34
  start-page: 8326
  issue: 6
  year: 2020
  ident: pone.0312676.ref023
  article-title: Comprehensive analysis on the whole Rho-GAP family reveals that ARHGAP4 suppresses EMT in epithelial cells under negative regulation by Septin9
  publication-title: FASEB J
  doi: 10.1096/fj.201902750RR
– volume: 21
  start-page: 63
  issue: 1
  year: 2023
  ident: pone.0312676.ref006
  article-title: Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stage I-III colorectal cancer
  publication-title: J Transl Med
  doi: 10.1186/s12967-023-03884-3
– volume: 63
  start-page: 797
  issue: 6
  year: 2019
  ident: pone.0312676.ref007
  article-title: The DNA methylation landscape in cancer
  publication-title: Essays Biochem
  doi: 10.1042/EBC20190037
– volume: 54
  start-page: 414
  issue: 2
  year: 2008
  ident: pone.0312676.ref008
  article-title: DNA methylation biomarkers for blood-based colorectal cancer screening
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2007.095992
– volume: 2
  start-page: 1
  issue: 1
  year: 2022
  ident: pone.0312676.ref002
  article-title: Cancer incidence and mortality in China, 2016.
  publication-title: J Natl Cancer Cent.
  doi: 10.1016/j.jncc.2022.02.002
– volume: 55
  start-page: 778
  issue: 7
  year: 2022
  ident: pone.0312676.ref012
  article-title: Systematic review: non-endoscopic surveillance for colorectal neoplasia in individuals with Lynch syndrome.
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/apt.16824
– volume: 9
  start-page: 514
  issue: 5
  year: 2018
  ident: pone.0312676.ref024
  article-title: Repression of Septin9 and Septin2 suppresses tumor growth of human glioblastoma cells
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-018-0547-4
– volume: 386
  start-page: 2261
  issue: 24
  year: 2022
  ident: pone.0312676.ref005
  article-title: Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2200075
– volume: 12
  start-page: 961
  issue: 9
  year: 2018
  ident: pone.0312676.ref015
  article-title: The blood mSEPT9 is capable of assessing the surgical therapeutic effect and the prognosis of colorectal cancer.
  publication-title: Biomark Med
  doi: 10.2217/bmm-2018-0012
– volume: 8
  start-page: 568818
  year: 2021
  ident: pone.0312676.ref019
  article-title: Screening and Prognostic Value of Methylated Septin9 and its Association With Clinicopathological and Molecular Characteristics in Colorectal Cancer.
  publication-title: Front Mol Biosci
  doi: 10.3389/fmolb.2021.568818
– volume: 13
  start-page: 398
  year: 2013
  ident: pone.0312676.ref022
  article-title: Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-13-398
– volume: 267
  start-page: 485
  year: 2021
  ident: pone.0312676.ref016
  article-title: mSEPT9 Can Monitor the Response and Predict the Prognosis of Stage IV Colorectal Cancer Patients with Liver Metastasis Undergoing Potentially Curative Surgery
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2021.06.008
– volume: 325
  start-page: 669
  issue: 7
  year: 2021
  ident: pone.0312676.ref003
  article-title: Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review
  publication-title: JAMA
  doi: 10.1001/jama.2021.0106
– volume: 392
  start-page: 769
  issue: 8–9
  year: 2011
  ident: pone.0312676.ref021
  article-title: Septin9 is involved in septin filament formation and cellular stability
  publication-title: Biol Chem
  doi: 10.1515/BC.2011.088
– volume: 19
  start-page: 450
  issue: 1
  year: 2019
  ident: pone.0312676.ref018
  article-title: The role of mSEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer
  publication-title: BMC Cancer
  doi: 10.1186/s12885-019-5663-8
– volume: 1
  start-page: 873
  issue: 9
  year: 2020
  ident: pone.0312676.ref010
  article-title: Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab
  publication-title: Nat Cancer
  doi: 10.1038/s43018-020-0096-5
– volume: 14
  start-page: 3510
  issue: 14
  year: 2022
  ident: pone.0312676.ref020
  article-title: Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients.
  publication-title: Cancers (Basel).
  doi: 10.3390/cancers14143510
– volume: 537
  start-page: 118
  year: 2022
  ident: pone.0312676.ref017
  article-title: Performance of circulating methylated Septin9 gene DNA in diagnosis and recurrence monitoring of colorectal cancer in Western China
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cca.2022.10.019
– volume: 315
  start-page: 35
  year: 2017
  ident: pone.0312676.ref025
  article-title: Methylation of Septin9 mediated by DNMT3a enhances hepatic stellate cells activation and liver fibrogenesis
  publication-title: Toxicol Appl Pharmacol
  doi: 10.1016/j.taap.2016.12.002
– volume: 71
  start-page: 209
  issue: 3
  year: 2021
  ident: pone.0312676.ref001
  article-title: Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
  publication-title: CA Cancer J Clin.
  doi: 10.3322/caac.21660
– volume: 13
  start-page: 1557
  issue: 19
  year: 2021
  ident: pone.0312676.ref013
  article-title: A combination of methylation and protein markers is capable of detecting gastric cancer detection by combined markers
  publication-title: Epigenomics
  doi: 10.2217/epi-2021-0080
– volume: 40
  start-page: 2846
  issue: 24
  year: 2022
  ident: pone.0312676.ref009
  article-title: Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices.
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.21.02615
SSID ssj0053866
Score 2.4604387
Snippet To explore the medical significance of methylated septin9 (mSEPT9) in monitoring recurrence and prognostic assessment in individuals with surgically treated...
Objective To explore the medical significance of methylated septin9 (mSEPT9) in monitoring recurrence and prognostic assessment in individuals with surgically...
ObjectiveTo explore the medical significance of methylated septin9 (mSEPT9) in monitoring recurrence and prognostic assessment in individuals with surgically...
Objective To explore the medical significance of methylated septin9 (mSEPT9) in monitoring recurrence and prognostic assessment in individuals with surgically...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e0312676
SubjectTerms Aged
Bioinformatics
Biology and life sciences
Biomarkers, Tumor - blood
Biomarkers, Tumor - genetics
Blood
Blood levels
Cancer
Cancer therapies
Carcinoembryonic antigen
Carcinoembryonic Antigen - blood
Carcinogenesis
Carcinogens
Care and treatment
Clinical medicine
Clinical Relevance
Clinical significance
Colon cancer
Colorectal cancer
Colorectal carcinoma
Colorectal Neoplasms - diagnosis
Colorectal Neoplasms - genetics
Colorectal Neoplasms - pathology
Colorectal Neoplasms - surgery
Differentiation
DNA Methylation
Female
Gene expression
Gene Expression Regulation, Neoplastic
Humans
Male
Medical prognosis
Medicine and Health Sciences
Metastasis
Middle Aged
Monitoring
Mortality
mRNA
Neoplasm Recurrence, Local - genetics
Patients
Peripheral blood
Physical Sciences
Plasma
Predictions
Prognosis
Relapse
Risk factors
Septins - genetics
Septins - metabolism
Spliceosomes
Statistical analysis
Surgery
Survival
Survival analysis
Telemedicine
Tissues
Tumors
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQnrggyquBAgYhAYe0m_iVHBfUqiDxEG1Rb5bj2GWlNlltdg_9Df3TzDjeaIMqwYHrzuw6mYf92TvzmZA3DNZwVbg6lYVxKVeMpcYIlfoKLwg0XorQIfflqzw-45_PxfnWVV9YE9bTA_eGO6hYCfviSnAlBTeyLgGCZ8JOLQNsI8sw-8Kat9lM9XMwZLGUsVGOqewg-mV_0TZuH8I4l8gxsrUQBb7-YVaeLC7b7jbI-Wfl5NZSdHSf3IsYks76Z98hd1zzgOzELO3ou0gl_f4huZnRwB9LW08B6dFNHyTFsg0sEkKfo_Dq5PD7aUnnDb0KSY6nfXSJZ_GhG5CapqZYytW03bxDtcjH2lE8yKXdehlm0MtrGirXXU2RDRtnUxgsjLJ8RM6ODk8_Hqfx-oXUwqZklTqACn6al7mwylrvWeV4XZraqtKV3tmsrhzzU8BPvFLWgXOEqCuWW2NYrsyUPSaTBgy-S6iHXQ32AFnlBJcmq5BWP1NMSsG4L2xC0o0v9KJn2dDhrzYFu5PeqBp9p6PvEvIBHTboIkd2-AAiR8fI0X-LnIS8RHfrvuF0yHQ9KwAVQ4zyLCGvgwbyZDRYiHNh1l2nP337-Q9KJz9GSm-jkm8hcKyJzQ_wTsi_NdLcG2lCttuReBeDc2OVTjOkBxEg5fDNTcDeLn41iPFHsbiuce066pRITZmQJ318D5ZleP8AjJ6QYhT5I9OPJc38V6ApzwJWLvjT_-GsZ-RuDk-IqCEv9shktVy75wAHV9WLkPm_Af9SXGc
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdGeeEFMb4WGGAQEvCQqom_kgeECto0kAaIrWhvkeM4o1KXdEkrbX8D_zR3rhMRVBCvvXOdnO_sO-fud4S8ZHCGq8QWoUy0DbliLNRaqLDMsUGgLqVwFXLHn-XRjH86E2c7pOvZ6gXYbg3tsJ_UrFmMry6v34HBv3VdG1TUDRov68qOQUljqeQNchPOJoWmesz77wpg3VL6Arq_jRwcUA7Hv9-tR8tF3W5zRf_MqPztiDq8Q25735JON8qwS3ZsdZfseutt6WsPMf3mHvk5pQ5XltYlBQ-QdvWRFNM5MHkIdQGJFycHX09TOq_ohTN-vAWkDd7RuypBqquCYopXVbfzFtk8TmtL8YKXtuvG7ayLa-oy2m1BESUbd1mYzM3S3Cezw4PTD0ehb8sQGghWVqEFF6KcxGksjDKmLFlueZHqwqjUpqU1UZFbVk7Ar-K5MpZrKUSRs9hozWKlJ-wBGVUg8D1CS4h2sDbIKCu41FGOcPuRYlIKxsvEBCTs1iJbbtA3MvcJTkHUshFqhmuX-bULyHtcsJ4XsbPdD3VznnlTzHKWRmmSC66kgIcrUgjqImEmhoG3LNM4IM9wubNNIWq_A2TTBLxl0F0eBeSF40D8jAoTdM71um2zj1--_wfTybcB0yvPVNagOEb7ogh4J8TlGnDuDzhhFzAD8h4qZyeVNmMIGyKAymFkp7Dbyc97Mv4pJt1Vtl57nhQhKwPycKPfvWQZ9iWA2QOSDDR_IPohpZr_cPDlkfOhE_7o38_1mNyKYW70E-Jkn4xWzdo-AQdwlT91Nv0Ln3ZbtQ
  priority: 102
  providerName: Scholars Portal
Title A study of the clinical significance of mSEPT9 in monitoring recurrence and prognosis in patients with surgically treated colorectal cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/39466813
https://www.proquest.com/docview/3121553964
https://www.proquest.com/docview/3121590243
https://pubmed.ncbi.nlm.nih.gov/PMC11515984
https://doaj.org/article/b39198b547654a6d986215c0c3099692
http://dx.doi.org/10.1371/journal.pone.0312676
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9NAEF5BeuGCKK8aSlgQEnBwG3tf9gmlVUJBaqn6QLlZ6_W6RGrtNE4OvfAH-NPMbDamRhXisofMJOvszOzOjme-IeQdgzNcJbYIZaJtyBVjodZChWWODQJ1KYWrkDs8kgfn_OtETHzArfFples90W3URW0wRr7LEAZBsFTyT7PrELtG4dtV30LjPtlA6DJM6VKT9sIFtiylL5djKtr10tmZ1ZXdAWWOJSKN3DqOHGp_uzf3Zpd1c5fj-Xf-5K0DafyIPPSeJB2uRL9J7tnqMdn0ttrQDx5Q-uMT8mtIHYosrUsK_h5dV0NSTN7AVCGUPBKvTkfHZymdVvTKmTrG_OgcI_KuJpDqqqCY0FXVzbRBNo_K2lAM59JmOXf76OUNdfnrtqCIiY17KkzmZpk_Jefj0dn-QeibMIQGriaL0ILDUA7iNBZGGVOWLLe8SHVhVGrT0pqoyC0rB-BF8VwZy7UUoshZbLRmsdID9oz0KljwLUJLuNtgJZBRVnCpoxzB9SPFpBSMl4kJSLiWRTZbYW1k7oWbgjvKalEzlF3mZReQPRRYy4tI2e6Den6RecPLcpZGaZILrqSAhytSuMJFwgwMA99YpnFAXqO4s1XZaWvv2TAB3xg0lUcBees4EC2jwnScC71smuzLt-__wXR60mF675nKGhTHaF8CAf8JUbg6nNsdTrB50yFvoXKuV6XJ_lgHfHOtsHeT37Rk_FFMsatsvfQ8KQJUBuT5Sr_blWXYhQBmD0jS0fzO0ncp1fSHAyuPnMec8Bf_fq6X5EEMc6NXECfbpLeYL-0rcPcWed_ZNIzJfoTj-HOfbOyNjo5P-i6AAuMhT3D8OfoNG6lcLw
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKcoALorwaKNQgEHBIu4ljOzkgtECrXfoA0W21t-A4TlmpTZbNrlB_A_-F38iM86BBFeLS63o2TjxP2zPfEPKcgQ-XoUldESrjBpIxVyku3SzBBoEqE9xWyO0fiOFR8HHCJyvkV1MLg2mVjU20hjotNJ6RbzGEQeAsEsHb2XcXu0bh7WrTQqMSi11z_gO2bOWb0Qfg7wvf39kevx-6dVcBV0OsvXANeMCs70c-11LrLGOJCdJIpVpGJsqM9tLEsKwPYUGQSG0CJThPE-ZrpZgvVZ_Bc6-R6-B4-6hRctJu8MB2CFGX5zHpbdXSsDkrcrMJyuMLRDa54P5sl4DWF_Rmp0V5WaD7d77mBQe4c5vcqiNXOqhEbZWsmPwOWa1tQ0lf1QDWr--SnwNqUWtpkVGIL2lTfUkxWQRTk1DScPDscPvzOKLTnJ5Z04JnjHSONwC2BpGqPKWYQJYX5bREshoFtqR4fEzL5dza7dNzavPlTUoRgxttOExmZ5nfI0dXwp77pJfDgq8RmsFeCiuPtDQ8EMpLEMzfk0wIzoIs1A5xG17EswrbI7YXfBL2RNWixsi7uOadQ94hw1paROa2PxTzk7hW9DhhkReFCQ-k4PByaQRbRo_rvmYQi4vId8gGsjuuylxb-xIPQojFQTMCzyHPLAWic-SY_nOilmUZjz4d_wfR4ZcO0cuaKCtAcLSqSy7gmxD1q0O53qEEG6M7w2sonM2qlPEfbYR_NgJ7-fDTdhgfiil9uSmWNU2EgJgOeVDJd7uyDLsewOwOCTuS31n67kg-_WbB0T0boYfBw3-_1wa5MRzv78V7o4PdR-SmD--BEYkfrpPeYr40jyHUXCRPrH5T8vWqDcpvrWuVCQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGkRAviPG1wGAGgYCHrE0c28kDQoWtWhmMiX2ob8FxnFFpS0rTCu1v4D_ir-POdcqCJsTLXuNL7Pg-fLbvfkfIcwZruIxN7otYGT-SjPlKcekXGRYIVIXgNkPu057YOYo-jPhohfxqcmEwrLKxidZQ55XGM_IuQxgEzhIRdQsXFrG_NXg7-e5jBSm8aW3KaSxEZNec_4DtW_1muAW8fhGGg-3D9zu-qzDga_C7Z76B1bDohUnItdS6KFhmojxRuZaJSQqjgzwzrOiBixBlUptICc7zjIVaKRZK1WPw3WvkumQ8QB2To-VmD-yIEC5Vj8mg6yRjc1KVZhMUKRSIcnJhKbQVA5brQmdyWtWXOb1_x25eWAwHt8kt58XS_kLsVsmKKe-QVWcnavrKgVm_vkt-9qlFsKVVQcHXpE0mJsXAEQxTQqnDxrOD7f3DhI5LembNDJ430ineBth8RKrKnGIwWVnV4xrJHCJsTfEomdbzqbXhp-fUxs6bnCIeN9pz6Mz2Mr1Hjq6EPfdJp4QJXyO0gH0VZiFpaXgkVJAhsH8gmRCcRUWsPeI3vEgnC5yP1F72SdgfLSY1Rd6ljnceeYcMW9IiSrd9UE1PUqf0acaSIIkzHknBYXB5AtvHgOueZuCXiyT0yAayO12kvC5tTdqPwS8HLYkCjzyzFIjUUaLMn6h5XafDz8f_QXTwpUX00hEVFQiOVi79Av4JEcBalOstSrA3utW8hsLZzEqd_tFMeLMR2Mubny6b8aMY3leaau5oEgTH9MiDhXwvZ5ZhBQTo3SNxS_JbU99uKcffLFB6YL31OHr473FtkBtgStKPw73dR-RmCMNA5ySM10lnNp2bx-B1zrInVr0p-XrV9uQ3f0WZPw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+study+of+the+clinical+significance+of+mSEPT9+in+monitoring+recurrence+and+prognosis+in+patients+with+surgically+treated+colorectal+cancer&rft.jtitle=PloS+one&rft.au=Li%2C+Rong&rft.au=Tang%2C+Jiadai&rft.au=Xiong%2C+Guangrui&rft.au=Zhang%2C+Ke&rft.date=2024-10-28&rft.pub=Public+Library+of+Science&rft.eissn=1932-6203&rft.volume=19&rft.issue=10&rft.spage=e0312676&rft_id=info:doi/10.1371%2Fjournal.pone.0312676&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon